BSAC - Banco Santander (Chile) S.A.
NYSE
->
Financial Services
->
Banks—Regional
Santiago de Chile,
Chile
Type: Equity
BSAC price evolution
BSAC
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | $352272 | $346744 | $355209 | $361146 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $70857888 | $72490748 | $68681981 | $69505768 |
| Current liabilities | ||||
| Accounts payable | $1087964 | $2452387 | $1262573 | $1341328 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $13788866 | $14287510 | $12306177 | $6784471 |
| Long term debt | $9135446 | $9409921 | $9303126 | $14639260 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $66490730 | $68298130 | $64513463 | $65585092 |
| Shareholders' equity | ||||
| Retained earnings | $3481097 | $3365179 | $3333256 | $3249610 |
| Other shareholder equity | -$5242 | -$63864 | -$56041 | -$220237 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2598433 | $1942857 | ||
| Short term investments | $952 | $299 | ||
| Net receivables | $121534 | $161590 | ||
| Inventory | $27415 | $31447 | ||
| Total current assets | $13591269 | $13964582 | ||
| Long term investments | $10529851 | $7173952 | ||
| Property, plant & equipment | $352272 | $371890 | $374818 | $388851 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $70857888 | $68164604 | $63841950 | $55703223 |
| Current liabilities | ||||
| Accounts payable | $1087964 | $1152750 | $26549059 | $23735140 |
| Deferred revenue | ||||
| Short long term debt | $4293205 | $2959692 | ||
| Total current liabilities | $13788866 | $5956637 | $45179078 | $39374220 |
| Long term debt | $9135446 | $14693129 | $12888133 | $12076603 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $66490730 | $64035796 | $59414377 | $51998449 |
| Shareholders' equity | ||||
| Retained earnings | $3481097 | $3404652 | $647065 | $410501 |
| Other shareholder equity | -$5242 | -$167147 | $2794845 | $2318287 |
| Total shareholder equity | $4333213 | $3620091 | ||
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $546310 | $555136 | $624314 | |
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $13280 | $6686 | $17838 | |
| Interest expense | ||||
| Net income | ||||
| Net income | $56616 | $127187 | $135683 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2417252 | $1990972 | $1565060 | |
| Cost of revenue | $22157 | $20300 | ||
| Gross Profit | $1968815 | $1544760 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $777707 | $748246 | ||
| Total operating expenses | $907190 | $839660 | ||
| Operating income | $1083782 | $725400 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $56341 | $221664 | $142533 | |
| Interest expense | ||||
| Net income | ||||
| Net income | $496404 | $842467 | $547614 | |
| Income (for common shares) | $845645 | $547614 | ||
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$100085 | -$61246 | -$26164 | -$12995 |
| Financing activities | ||||
| Dividends paid | -$485191 | -$485191 | -$485191 | |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$48872 | $306900 | -$275463 | $29217 |
| Effect of exchange rate | -$1778 | $5500 | $5500 | -$2801 |
| Change in cash and equivalents | $680838 | $483142 | $375744 | $677840 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $842467 | $547614 | ||
| Operating activities | ||||
| Depreciation | $89803 | $84042 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$3179429 | -$1458507 | ||
| Investing activities | ||||
| Capital expenditures | -$57995 | -$50613 | ||
| Investments | -$7499 | -$7499 | ||
| Total cash flows from investing | -$100085 | -$93603 | -$91770 | -$70105 |
| Financing activities | ||||
| Dividends paid | -$485191 | -$464977 | -$310468 | -$331255 |
| Sale and purchase of stock | ||||
| Net borrowings | $549129 | $433345 | ||
| Total cash flows from financing | -$48872 | -$1149454 | $2830910 | $740604 |
| Effect of exchange rate | -$1778 | $25904 | $437564 | -$28706 |
| Change in cash and equivalents | $680838 | -$812009 | -$2725 | -$816714 |
News
Fundamentals
| Market cap | $8.53B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 471.12M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |